Bioprocess miniaturization: Development and optimisation

26 November 2013, London, United Kingdom

Introduction

rapidly expanding area of interest since the technologies promise to reduce biopharmaceutical development time and cost. This meeting will focus on recent technologies used in high throughput bioprocess development, from clone selection through to analysis of final product and formulation. Expert speakers will describe the development and use of current miniaturisation technologies together with the technical and regulatory hurdles that must be overcome to facilitate wider industrial uptake.